Biology of Transforming Growth Factor-β Signaling

被引:48
|
作者
Ikushima, Hiroaki [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan
关键词
TGF-beta; Smad; non-Smad; cell proliferation; fibrosis; EMT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; CRYSTAL-STRUCTURE; C-MYC; MEDIATED DEGRADATION; NEGATIVE REGULATORS; CELLULAR-RESPONSES; TUMOR-SUPPRESSOR; SMAD PROTEINS;
D O I
10.2174/138920111798808419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor (TGF)-beta signaling has been implicated as an important regulator of almost all major cell behaviors, including proliferation, differentiation, cell death, and motility. Which cell responses are induced or suppressed in response to TGF-beta depends on the cell type and the context in which TGF-beta signaling is received. TGF-beta ligands, their receptors, and intracellular Smad effectors lie in the center of TGF-beta signaling. TGF-beta ligands signal via receptor serine/threonine kinases that phosphorylate and activate Smad proteins as well as other signaling molecules. Smad complexes associate with chromatin and regulate transcription, defining the biological response of a cell to TGF-beta stimulation. In addition, numerous factors constitute complex networks to regulate TGF-beta signaling and to provide this cytokine with the ability to induce cellular context-specific cell responses. Perturbation of the network is strongly involved in various pathological situations, including cancer and fibrosis. In this review, we consider the basic machinery of TGF-beta signaling and describe several factors which make up TGF-beta signaling networks. We also address major TGF-beta-induced cell responses involved in several physiological and pathological conditions, including cell proliferation, fibrosis, and epithelial-mesenchymal transition.
引用
收藏
页码:2099 / 2107
页数:9
相关论文
共 50 条
  • [21] Abrogation of transforming growth factor-ß signaling in pancreatic cancer
    Lin, X
    Feng, XH
    WORLD JOURNAL OF SURGERY, 2005, 29 (03) : 312 - 316
  • [22] Roles of transforming growth factor-β signaling in liver disease
    Wang, Xiao-Ling
    Yang, Meng
    Wang, Ying
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (07)
  • [23] Transforming growth factor-β signaling in normal and malignant hematopoiesis
    Kim, SJ
    Letterio, J
    LEUKEMIA, 2003, 17 (09) : 1731 - 1737
  • [24] Transforming growth factor-β signaling in normal and malignant Hematopoiesis
    Isufi, Iris
    Seetharam, Mahesh
    Zhou, Li
    Sohal, Davendra
    Opalinska, Joanna
    Pahanish, Perry
    Verma, Amit
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (07): : 543 - 552
  • [25] Transforming growth factor-β signaling in breast cancer subtypes
    Ganapathy, Vidya
    Reiss, Michael
    CANCER RESEARCH, 2010, 70
  • [26] Transforming Growth Factor-β Signaling Pathway Activation in Keratoconus
    Engler, Christoph
    Chakravarti, Shukti
    Doyle, Jefferson
    Eberhart, Charles G.
    Meng, Huan
    Stark, Walter J.
    Kelliher, Clare
    Jun, Albert S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (05) : 752 - 759
  • [27] Transforming growth factor-β signaling in cancer invasion and metastasis
    Leivonen, Suvi-Katri
    Kahari, Veli-Matti
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) : 2119 - 2124
  • [28] Transforming growth factor-β signaling and its role in cancer
    Souchelnytskyi, S
    EXPERIMENTAL ONCOLOGY, 2002, 24 (01) : 3 - 12
  • [29] Abrogation of Transforming Growth Factor-β Signaling in Pancreatic Cancer
    Xia Lin
    Xin-Hua Feng
    World Journal of Surgery, 2005, 29 : 312 - 316
  • [30] Transforming growth factor-β signaling in normal and malignant hematopoiesis
    S-J Kim
    J Letterio
    Leukemia, 2003, 17 : 1731 - 1737